How do international regulatory differences affect cancer treatment availability?
Differences in regulatory standards, approval processes, and healthcare infrastructure can lead to variations in the availability of cancer treatments worldwide. Harmonizing regulations through initiatives like the International Council for Harmonisation (ICH) can help mitigate these disparities and promote global access to effective cancer therapies.
